{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:00Z","timestamp":1793913900595,"version":"4.8.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["DP2HD084068"],"award-info":[{"award-number":["DP2HD084068"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG057557"],"award-info":[{"award-number":["R01 AG057557"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG061388"],"award-info":[{"award-number":["R01 AG061388"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56 AG062272"],"award-info":[{"award-number":["R56 AG062272"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-16-049-01 - MPC"],"award-info":[{"award-number":["RSG-16-049-01 - MPC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["MH091791"],"award-info":[{"award-number":["MH091791"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["MH107077"],"award-info":[{"award-number":["MH107077"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229819","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T13:29:05Z","timestamp":1584970145000},"page":"e0229819","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":137,"title":["Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer\u2019s disease in patients with rheumatoid arthritis and psoriasis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-2485","authenticated-orcid":true,"given":"Mengshi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"issue":"10043","key":"pone.0229819.ref001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"P Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"pone.0229819.ref002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"CR Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"2","key":"pone.0229819.ref003","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"DV Hansen","year":"2018","journal-title":"J Cell Biol"},{"issue":"6005","key":"pone.0229819.ref004","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"F Ginhoux","year":"2010","journal-title":"Science"},{"issue":"2","key":"pone.0229819.ref005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases","volume":"165","author":"MA Willrich","year":"2015","journal-title":"Transl Res"},{"issue":"9","key":"pone.0229819.ref006","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer's disease","volume":"74","author":"E Tarkowski","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0229819.ref007","article-title":"Targeting TNF: a therapeutic strategy for Alzheimer's disease","author":"X Cheng","year":"2014","journal-title":"Drug Discov Today"},{"issue":"8","key":"pone.0229819.ref008","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s11064-019-02817-1","article-title":"TREM2 Attenuates Abeta1-42-Mediated Neuroinflammation in BV-2 Cells by Downregulating TLR Signaling","volume":"44","author":"H Long","year":"2019","journal-title":"Neurochem Res"},{"key":"pone.0229819.ref009","first-page":"29","article-title":"Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease","volume":"1","author":"FE McAlpine","year":"2008","journal-title":"J Inflamm Res"},{"issue":"7638","key":"pone.0229819.ref010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"SA Liddelow","year":"2017","journal-title":"Nature"},{"issue":"13","key":"pone.0229819.ref011","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"J Keffer","year":"1991","journal-title":"EMBO J"},{"issue":"2","key":"pone.0229819.ref012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/exnr.2002.7871","article-title":"TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice","volume":"174","author":"W Pan","year":"2002","journal-title":"Exp Neurol"},{"issue":"11","key":"pone.0229819.ref013","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis","volume":"30","author":"RC Chou","year":"2016","journal-title":"CNS Drugs"},{"issue":"6","key":"pone.0229819.ref014","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/amiajnl-2011-000782","article-title":"Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data","volume":"19","author":"DC Kaelber","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"pone.0229819.ref015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbi.2013.10.009","article-title":"Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine","volume":"52","author":"VN Patel","year":"2014","journal-title":"J Biomed Inform"},{"key":"pone.0229819.ref016","article-title":"Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings","author":"T Winhusen","year":"2019","journal-title":"Addiction"},{"issue":"6","key":"pone.0229819.ref017","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.174.6.1483","article-title":"A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity","volume":"174","author":"K Peppel","year":"1991","journal-title":"J Exp Med"},{"issue":"9","key":"pone.0229819.ref018","first-page":"899","article-title":"Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen","volume":"12","author":"LS Jespers","year":"1994","journal-title":"Biotechnology (N Y)"},{"issue":"16","key":"pone.0229819.ref019","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"DM Knight","year":"1993","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"pone.0229819.ref020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"WM Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"issue":"5","key":"pone.0229819.ref021","first-page":"40","article-title":"The Unified Medical Language System (UMLS) of the National Library of Medicine","volume":"61","author":"C. Lindberg","year":"1990","journal-title":"J Am Med Rec Assoc"},{"key":"pone.0229819.ref022","first-page":"683","article-title":"The Need for a Global Language\u2014SNOMED CT Introduction","volume":"225","author":"J. Millar","year":"2016","journal-title":"Stud Health Technol Inform"},{"issue":"4","key":"pone.0229819.ref023","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"SJ Nelson","year":"2011","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"pone.0229819.ref024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/jamia.1998.0050276","article-title":"Development of the Logical Observation Identifier Names and Codes (LOINC) vocabulary","volume":"5","author":"SM Huff","year":"1998","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"pone.0229819.ref025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13607863.2012.742488","article-title":"The impact of alcohol on Alzheimer's disease: a systematic review","volume":"17","author":"AK Piazza-Gardner","year":"2013","journal-title":"Aging Ment Health"},{"issue":"6","key":"pone.0229819.ref026","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders","volume":"67","author":"LA Profenno","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"pone.0229819.ref027","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective","volume":"11","author":"M Baumgart","year":"2015","journal-title":"Alzheimers Dement"},{"key":"pone.0229819.ref028","doi-asserted-by":"crossref","first-page":"e4230","DOI":"10.1136\/bmj.e4230","article-title":"Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study","volume":"345","author":"D Di Giuseppe","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"pone.0229819.ref029","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.38634","article-title":"Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study","volume":"66","author":"B Lu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"pone.0229819.ref030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-015-0601-x","article-title":"Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis","volume":"17","author":"B Qin","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"pone.0229819.ref031","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies","volume":"69","author":"D Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0229819.ref032","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"L Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"18","key":"pone.0229819.ref033","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000004602","article-title":"Female sex, early-onset hypertension, and risk of dementia","volume":"89","author":"P Gilsanz","year":"2017","journal-title":"Neurology"},{"key":"pone.0229819.ref034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","article-title":"A general overview of Mantel-Haenszel methods: applications and recent developments","volume":"9","author":"SJ Kuritz","year":"1988","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"pone.0229819.ref035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"S Salloway","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0229819.ref036","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"RS Doody","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0229819.ref037","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"A. Alzheimer's","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"13","key":"pone.0229819.ref038","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"D Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"pone.0229819.ref039","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/acr.22788","article-title":"Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry","volume":"68","author":"EG Favalli","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"pone.0229819.ref040","doi-asserted-by":"crossref","first-page":"rkz007","DOI":"10.1093\/rap\/rkz007","article-title":"Eight-year survival study of first-line tumour necrosis factor alpha inhibitors in rheumatoid arthritis: real-world data from a university centre registry","volume":"3","author":"CG Papadopoulos","year":"2019","journal-title":"Rheumatol Adv Pract"},{"issue":"4","key":"pone.0229819.ref041","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"MT Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"21","key":"pone.0229819.ref042","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"J Butchart","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"pone.0229819.ref043","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease","volume":"75","author":"I Peter","year":"2018","journal-title":"JAMA Neurol"},{"issue":"9504","key":"pone.0229819.ref044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"S Tyring","year":"2006","journal-title":"Lancet"},{"key":"pone.0229819.ref045","article-title":"Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease","author":"ME Gurney","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"9","key":"pone.0229819.ref046","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20180484","article-title":"TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease","volume":"215","author":"P Chakrabarty","year":"2018","journal-title":"J Exp Med"},{"key":"pone.0229819.ref047","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects","volume":"302","author":"L. Probert","year":"2015","journal-title":"Neuroscience"},{"issue":"11","key":"pone.0229819.ref048","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nn.4142","article-title":"Do glia drive synaptic and cognitive impairment in disease?","volume":"18","author":"WS Chung","year":"2015","journal-title":"Nat Neurosci"},{"issue":"9","key":"pone.0229819.ref049","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"MW Salter","year":"2017","journal-title":"Nat Med"},{"issue":"9","key":"pone.0229819.ref050","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease","volume":"49","author":"R Sims","year":"2017","journal-title":"Nat Genet"},{"issue":"6","key":"pone.0229819.ref051","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, Microglia, and Neurodegenerative Diseases","volume":"23","author":"FL Yeh","year":"2017","journal-title":"Trends Mol Med"},{"key":"pone.0229819.ref052","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.01.028","article-title":"TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice","volume":"105","author":"T Jiang","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"pone.0229819.ref053","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"SM Bemiller","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"1","key":"pone.0229819.ref054","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1038\/s41598-018-25553-y","article-title":"The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-alpha levels and IMT-F","volume":"8","author":"V Gorenjak","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0229819.ref055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2017.00460","article-title":"Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics","volume":"8","author":"P Li","year":"2017","journal-title":"Front Pharmacol"},{"issue":"11","key":"pone.0229819.ref056","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"SL Jin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0229819.ref057","article-title":"Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury","author":"M Ghosh","year":"2012","journal-title":"Glia"},{"issue":"5","key":"pone.0229819.ref058","doi-asserted-by":"crossref","first-page":"e0178013","DOI":"10.1371\/journal.pone.0178013","article-title":"Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury","volume":"12","author":"NM Wilson","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"pone.0229819.ref059","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"SC Vlad","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"pone.0229819.ref060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","article-title":"Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial","volume":"27","author":"JM Leoutsakos","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"issue":"18","key":"pone.0229819.ref061","doi-asserted-by":"crossref","first-page":"e2070","DOI":"10.1212\/WNL.0000000000007232","article-title":"INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","volume":"92","author":"PF Meyer","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"pone.0229819.ref062","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"SA Reines","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"pone.0229819.ref063","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.1000906","article-title":"Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood","volume":"185","author":"TH Page","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"pone.0229819.ref064","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.54.3.588","article-title":"A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study","volume":"54","author":"PS Aisen","year":"2000","journal-title":"Neurology"},{"key":"pone.0229819.ref065","unstructured":"https:\/\/www.washingtonpost.com\/business\/economy\/pfizer-had-clues-its-blockbuster-drug-could-prevent-alzheimers-why-didnt-it-tell-the-world\/2019\/06\/04\/9092e08a-7a61-11e9-8bb7-0fc796cf2ec0_story.html"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:34:50Z","timestamp":1722612890000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229819"}},"subtitle":[],"editor":[{"given":"Antony","family":"Bayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229819","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19007666","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]}}}